Business context and reporting period
The Scotts Miracle-Gro Company manufactures and markets lawn and garden products and indoor/hydroponic gardening products. This unaudited Form 10-Q covers the fiscal second quarter and six months ended March 30, 2024; the comparable period ended April 1, 2023. Results are seasonal, with consumer sales concentrated in the second and third fiscal quarters. Dollar amounts below are in millions except per-share data.
Financial performance and position
| Metric | Three months | Six months |
|---|---|---|
| Net sales | $1,525.4, down 0.4% | $1,935.8, down 5.9% |
| Gross margin | $463.7; 30.4% of sales, versus 26.9% | $525.9; 27.2% of sales, versus 24.7% |
| Operating income | $272.1, versus $206.2 | $224.8, versus $164.4 |
| Net income | $157.5; diluted EPS $2.74 | $77.0; diluted EPS $1.34 |
| Interest expense | $44.1, versus $48.3 | $86.8, versus $91.0 |
Higher gross-margin rates and lower restructuring charges and SG&A supported earnings. Quarterly sales were nearly flat; six-month sales declined mainly because of lower Hawthorne volume and lower pricing in U.S. Consumer and Hawthorne. Six-month equity-method losses were $29.5, including a $10.4 impairment charge related to Bonnie Plants.
- Operating cash flow was negative $39.0 for the six months, versus negative $566.9. Working-capital movements and sales of receivables contributed to the comparison; the company sold $955.5 of receivables during the period and recorded $12.9 of related discounts.
- Investing cash outflow was $71.1, including $54.2 of capital expenditures and $21.4 to buy an additional 5% of Bonnie Plants, restoring ownership to 50%.
- Financing cash inflow was $142.8, including net borrowings; dividends paid were $76.2. Cash ended at $65.1.
- Total debt was $2,837.2, including $314.2 of revolver borrowings; long-term debt was $2,760.5. Cash plus $857.8 of borrowing availability under the credit agreement were reported at quarter-end. Total liabilities exceeded assets, resulting in a $250.9 equity deficit.
Material changes and management commentary
- U.S. Consumer sales rose 1.7% for the quarter but declined 2.3% for the six months. Hawthorne sales fell 28.4% and 34.6%, respectively; its segment loss improved to $3.4 for the quarter and $13.0 for the six months. Other-segment sales and profit also declined.
- The company expects at least $300 of annualized run-rate savings from restructuring, nearly all by fiscal year-end 2024. It incurred $77.0 of restructuring and other charges in the quarter, largely tied to Hawthorne inventory reductions and distribution-center closures. Management expects the initiative to improve gross margin and reduce SG&A.
- Hawthorne is focusing on its proprietary Signature brands and ending distribution of other companies’ products, which management expects to reduce future segment sales while helping optimize operations and profitability. A distribution partnership with BFG Supply was announced.
- Management expects cannabis oversupply to continue pressuring Hawthorne. It also cited inflation, volatile commodity costs, elevated interest rates, macroeconomic uncertainty and geopolitical conflicts as ongoing headwinds. Targeted price reductions were implemented on certain products in fiscal 2024.
Debt, liquidity, risks and contingencies
The company reported compliance with debt covenants at March 30 and expects to remain compliant over the next 12 months, but emphasized uncertainty in its projections. Its leverage ratio was 6.95 against a 7.75 maximum for the second quarter; the maximum tightens to 6.50 in fiscal Q3 2024 and 6.00 in Q4. Fixed-charge coverage was 0.95 against a 0.75 minimum for Q2 and Q3; the minimum becomes 1.00 in Q4. Interest coverage was 2.48 against a 2.00 minimum. The credit agreement restricts discretionary payments and certain investments, raises borrowing costs, and adds collateral, including intellectual property. If a covenant breach caused acceleration, the company said it lacks cash and available liquidity to repay $2,814.2 of credit-facility and senior-note indebtedness. Contingency options include further cost reductions, cash-management measures, lender amendments, and financing that could include equity; success is not assured.
Other matters include $2.9 accrued for environmental actions and asbestos-related claims for which no accrual was recorded because loss was not considered probable. The company said existing legal proceedings had no material developments and risk factors had not materially changed. Disclosure controls were deemed effective.
Most important facts for investors to verify
- Progress toward the $300 annualized savings target, remaining restructuring costs and actual cash benefits.
- Hawthorne demand, cannabis-market conditions, and the sales and profitability effects of its product-distribution shift.
- Quarterly covenant calculations and headroom as leverage limits tighten and fixed-charge coverage requirements rise.
- Cash generation and working-capital dependence on receivables sales, including facility availability, discount expense and renewal or replacement after October 25, 2024.
- Dividend capacity under credit-agreement restrictions and whether any additional financing or lender amendments become necessary.